Chloramphenicol - A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli?
- PMID: 27042458
- PMCID: PMC4800523
- DOI: 10.7860/JCDR/2016/14989.7167
Chloramphenicol - A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli?
Abstract
Introduction: Multidrug-resistant gram-negative bacteria cause infections which are hard to treat and cause high morbidity and mortality. Due to limited therapeutic options there is a renewed interest upon older antimicrobials which had fallen into disuse as a result of toxic side effects. One such antibiotic is chloramphenicol which was sidelined due to reports linking its use with the development of aplastic anaemia.
Aim: A study was conducted to evaluate the susceptibility of chloramphenicol in light of the emerging problem of multi-drug resistant gram negative bacteria (MDR GNB).
Materials and methods: A total of 483 MDR GNB of the 650 consecutive Gram Negative Bacteria isolated from various clinical samples of patients admitted at a tertiary care hospital in Jaipur between January-June 2014 were screened for chloramphenicol susceptibility by the disc diffusion method as per CLSI guidelines.
Results: The MDR GNB isolates were obtained from 217 (45%) urine, 163 (34%) from respiratory samples, 52(11%) from pus, 42 (9%) from blood and 9 (2%) from body fluids. A 68% of the MDR GNB isolates were found to be sensitive to chloramphenicol.
Conclusion: Clinicians should always check for the local susceptibility of Gram-negative bacteria to chloramphenicol. This antibiotic has a potential to play a role in the therapeutic management of infections due to MDR GNB pathogens.
Keywords: Antimicrobials; Disc diffusion method; Gram negative bacteria.
Figures
Similar articles
-
Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wards.Surg Infect (Larchmt). 2012 Oct;13(5):326-31. doi: 10.1089/sur.2011.115. Epub 2012 Sep 26. Surg Infect (Larchmt). 2012. PMID: 23013255
-
High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.Medicina (Kaunas). 2019 Sep 13;55(9):588. doi: 10.3390/medicina55090588. Medicina (Kaunas). 2019. PMID: 31540314 Free PMC article.
-
The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.Clin Infect Dis. 2005 Jun 15;40(12):1792-8. doi: 10.1086/430314. Epub 2005 May 6. Clin Infect Dis. 2005. PMID: 15909268
-
The respiratory threat posed by multidrug resistant Gram-negative bacteria.Respirology. 2017 Oct;22(7):1288-1299. doi: 10.1111/resp.13115. Epub 2017 Jul 6. Respirology. 2017. PMID: 28681941 Review.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
Cited by
-
The Role of Nitroreductases in Resistance to Nitroimidazoles.Biology (Basel). 2021 May 1;10(5):388. doi: 10.3390/biology10050388. Biology (Basel). 2021. PMID: 34062712 Free PMC article. Review.
-
Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii.Front Public Health. 2020 Sep 2;8:451. doi: 10.3389/fpubh.2020.00451. eCollection 2020. Front Public Health. 2020. PMID: 33014966 Free PMC article.
-
Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales.Nat Commun. 2024 Oct 18;15(1):9019. doi: 10.1038/s41467-024-53391-2. Nat Commun. 2024. PMID: 39424629 Free PMC article.
-
Occurrence and mechanisms of tigecycline resistance in carbapenem- and colistin-resistant Klebsiella pneumoniae in Thailand.Sci Rep. 2024 Mar 3;14(1):5215. doi: 10.1038/s41598-024-55705-2. Sci Rep. 2024. PMID: 38433246 Free PMC article.
-
In Silico Drug Repurposing Endorse Amprenavir, Darunavir and Saquinavir to Target Enzymes of Multidrug Resistant Uropathogenic E. Coli.Indian J Microbiol. 2024 Sep;64(3):1153-1214. doi: 10.1007/s12088-024-01282-x. Epub 2024 Apr 26. Indian J Microbiol. 2024. PMID: 39282172
References
-
- Kallen AJ, Srinivasan A. Current epidemiology of multidrug-resistant Gram-negative bacilli in the United States. Infect Control Hosp Epidemiol. 2010;31(Suppl 1):S51–54. - PubMed
-
- Lautenbach E, Polk RE. Resistant gram-negative bacilli: A neglected healthcare crisis? American Journal of Health-System Pharmacy. 2007;64((23) Suppl 14):S3–S21. - PubMed
-
- Xu ZQ, Flavin MT, Flavin J. Combating multidrug-resistant Gram-negative bacterial infections. Expert Opin Investig Drugs. 2014;23(2):163–82. - PubMed
-
- Madhavan HN, Bhagyalakshmi R. Farewell, Chloramphenicol? Is this True? : A Review. Research and Reviews. Journal of Microbiology and Biotechnology. 2014;3(1):13–26.
LinkOut - more resources
Full Text Sources
Other Literature Sources